Overview


Liquid disperse systems for pharmaceutical emulsions consist of small globules that are distributed in a vehicle where it is impermeable. The dispersed or discontinuous phase of an emulsion is called the dispersion medium. Dispersed phase globules have a diameter that is usually between 0.1 and 10 mm. However, it can be smaller or larger than 0.01 mm. Emulsification is the process of forming an emulsion. These systems can be emulsified in a variety of ways, from creams and lotions with a low viscosity to semisolid creams and ointments. Pharmacological emulsions can be used to administer nutrients, drugs, or diagnostic agents. Emulsions that can be used externally include lotions and topical creams. There are many ways to prepare emulsions, depending on what the components of the emulsion are and the available instrumentation.

Small scale preparations such as those in a pharmacy or laboratory may use equipment like a mortar and pestle, homogenizers, and mechanical blenders. The shelf life of emulsions should be maintained under the recommended packaging and storage conditions. Topically applied emulsions allow the formulation scientist to control the viscosity and appearance of cosmetic and dermatologic products. O/w emulsions can be used as water-washable bases. Water-in-oil emulsions (w/o), on the other hand, are widely used for dry skin treatment and emollients to create an occlusive effect. Semisolid preparations such as creams and ointments are liquids dispersed in solids that can be applied topically. Other clinical uses include radiopaque and parenteral Emulsions, and blood replacement therapy. There are more cases of dry skin conditions like ichthyosis and eczema. All over the globe. These conditions may require creams that contain liquid paraaffin, which can be used in the form an emulsion. This is driving the market for pharmaceutical emulsions to grow.

A lot of patients who have low vitamin levels are also being admitted to hospitals. For those who require total parenteral nutrition. These cases often require the use of parenteral vitamins in an emulsion by healthcare providers form. This has also led to the growth of the market for pharmaceutical emulsions. Creams and external emulsions can be used to prepare a wide range of cosmetic products. The popularity of cosmetic products has also increased. The pharmaceutical industry has seen a rise in popularity due to people focusing on external beauty and experience. Market for emulsions However, the regulatory requirements for approval of pharmaceutical emulsions are increasing. This is a constraint Factor that influences the market for pharmaceutical emulsions.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Pharmaceutical Emulsion Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Pharmaceutical Emulsion Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Johnson and Johnson Inc
  • Alkemes PLC
  • Teva Pharmaceutical Industries Ltd
  • Novartis AG
  • F.Hoffmann-La Roche
  • Omeros Corporation
  • Indivior PLC
  • Glenmark Pharmaceuticals Ltd

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Type

  • Oil-in-water Emulsion
  • Water-in-oil Emulsion

By Particle Size

  • Macroemulsions
  • Miniemulsions
  • Microemulsions
  • Nanoemulsions

By Mode of Administration

  • Oral Emulsions
  • External Emulsions
  • Parenteral Emulsions
  • Rectal Emulsions

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Sales

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Pharmaceutical Emulsion Market By Type, By Particle Size, By Mode of Administration, By Distribution Channel and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions—North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping-product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Pharmaceutical Emulsion Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Pharmaceutical Emulsion Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Pharmaceutical Emulsion Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Pharmaceutical Emulsion Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Oil-in-water Emulsion
        2. Water-in-oil Emulsion

  • 8.   Pharmaceutical Emulsion Market, By Particle Size Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Macroemulsions
        2. Miniemulsions
        3. Microemulsions
        4. Nanoemulsions

  • 9.   Pharmaceutical Emulsion Market, By Mode of Administration Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Oral Emulsions
        2. External Emulsions
        3. Parenteral Emulsions
        4. Rectal Emulsions

  • 10.   Pharmaceutical Emulsion Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Sales

  • 11.   North America Pharmaceutical Emulsion Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Pharmaceutical Emulsion Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Pharmaceutical Emulsion Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Pharmaceutical Emulsion Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Johnson and Johnson Inc
                   1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Alkemes PLC
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Teva Pharmaceutical Industries Ltd
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Novartis AG
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. F.Hoffmann-La Roche
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Omeros Corporation
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Indivior PLC
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Glenmark Pharmaceuticals Ltd
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients